25 XP   0   0   10

Millennium Pharmacon International
Buy, Hold or Sell?

Let's analyse Millennium Pharmacon International together

PenkeI guess you are interested in Millennium Pharmacon International. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Millennium Pharmacon International. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Millennium Pharmacon International

I send you an email if I find something interesting about Millennium Pharmacon International.

Quick analysis of Millennium Pharmacon International (30 sec.)










What can you expect buying and holding a share of Millennium Pharmacon International? (30 sec.)

How much money do you get?

How much money do you get?
Rp0.00
When do you have the money?
1 year
How often do you get paid?
72.5%

What is your share worth?

Current worth
Rp225.28
Expected worth in 1 year
Rp247.90
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
Rp30.62
Return On Investment
21.1%

For what price can you sell your share?

Current Price per Share
Rp145.00
Expected price per share
Rp135.00 - Rp150.00
How sure are you?
50%

1. Valuation of Millennium Pharmacon International (5 min.)




Live pricePrice per Share (EOD)

Rp145.00

Intrinsic Value Per Share

Rp-7,995.53 - Rp-9,608.92

Total Value Per Share

Rp-7,770.25 - Rp-9,383.64

2. Growth of Millennium Pharmacon International (5 min.)




Is Millennium Pharmacon International growing?

Current yearPrevious yearGrowGrow %
How rich?$28.7m$24.8m$2.5m9.3%

How much money is Millennium Pharmacon International making?

Current yearPrevious yearGrowGrow %
Making money$683.9k$584.9k$98.9k14.5%
Net Profit Margin0.8%0.7%--

How much money comes from the company's main activities?

3. Financial Health of Millennium Pharmacon International (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  


Richest
#32 / 41

Most Revenue
#27 / 41

Most Profit
#30 / 41

What can you expect buying and holding a share of Millennium Pharmacon International? (5 min.)

Welcome investor! Millennium Pharmacon International's management wants to use your money to grow the business. In return you get a share of Millennium Pharmacon International.

What can you expect buying and holding a share of Millennium Pharmacon International?

First you should know what it really means to hold a share of Millennium Pharmacon International. And how you can make/lose money.

Speculation

The Price per Share of Millennium Pharmacon International is Rp145.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Millennium Pharmacon International.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Millennium Pharmacon International, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is Rp225.28. Based on the TTM, the Book Value Change Per Share is Rp5.65 per quarter. Based on the YOY, the Book Value Change Per Share is Rp3.42 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is Rp2.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Millennium Pharmacon International.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 Rp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per Share
Usd Eps0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Price Per Share0.02-0.02-0.01-0.01-0.01-
Price to Earnings Ratio14.09-6.59--18.85--10.97-9.39-
Price-to-Total Gains Ratio32.98-50.29-4.37--104.89--21.66-
Price to Book Ratio0.71-0.98-0.66-0.68-0.75-
Price-to-Total Gains Ratio32.98-50.29-4.37--104.89--21.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0145
Number of shares68965
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (68965 shares)52.7926.68
Gains per Year (68965 shares)211.16106.74
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
155156201436397
211031241287127204
3166468623130190311
4221624834174253418
52767801045217316525
63319361256261380632
738610921467304443739
844112481678348506846
949714041889391570953
10552156021004346331060

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%10.02.00.083.3%15.05.00.075.0%35.05.00.087.5%68.05.01.091.9%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%14.06.00.070.0%34.06.00.085.0%67.07.00.090.5%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%29.00.011.072.5%29.00.045.039.2%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%16.04.00.080.0%36.04.00.090.0%69.05.00.093.2%

Fundamentals of Millennium Pharmacon International

About Millennium Pharmacon International

PT Millennium Pharmacon International Tbk engages in the distribution and trading of prescription and non-prescription medicines and medical devices in Indonesia. As of December 31, 2022, it operated 33 branch offices in Java, Bali, Sumatera, Kalimantan, and Sulawesi Islands. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Bhd.

Fundamental data was last updated by Penke on 2024-03-12 22:24:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Millennium Pharmacon International.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Millennium Pharmacon International earns for each Rp1 of revenue.

  • Above 10% is considered healthy but always compare Millennium Pharmacon International to the Medical Distribution industry mean.
  • A Net Profit Margin of 0.4% means that Rp0.00 for each Rp1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Millennium Pharmacon International:

  • The MRQ is 0.4%. The company is not making a profit/loss.
  • The TTM is 0.8%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ0.4%TTM0.8%-0.4%
TTM0.8%YOY0.7%+0.1%
TTM0.8%5Y0.5%+0.4%
5Y0.5%10Y0.6%-0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4%1.9%-1.5%
TTM0.8%2.2%-1.4%
YOY0.7%2.4%-1.7%
5Y0.5%2.2%-1.7%
10Y0.6%2.1%-1.5%
1.1.2. Return on Assets

Shows how efficient Millennium Pharmacon International is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Millennium Pharmacon International to the Medical Distribution industry mean.
  • 0.2% Return on Assets means that Millennium Pharmacon International generated Rp0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Millennium Pharmacon International:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM0.5%-0.2%
TTM0.5%YOY0.4%+0.0%
TTM0.5%5Y0.3%+0.2%
5Y0.3%10Y0.4%-0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%0.8%-0.6%
TTM0.5%0.9%-0.4%
YOY0.4%0.8%-0.4%
5Y0.3%0.9%-0.6%
10Y0.4%1.0%-0.6%
1.1.3. Return on Equity

Shows how efficient Millennium Pharmacon International is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Millennium Pharmacon International to the Medical Distribution industry mean.
  • 1.3% Return on Equity means Millennium Pharmacon International generated Rp0.01 for each Rp1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Millennium Pharmacon International:

  • The MRQ is 1.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.3%TTM2.5%-1.2%
TTM2.5%YOY2.3%+0.1%
TTM2.5%5Y1.4%+1.0%
5Y1.4%10Y1.8%-0.3%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3%2.1%-0.8%
TTM2.5%2.5%0.0%
YOY2.3%2.2%+0.1%
5Y1.4%2.3%-0.9%
10Y1.8%2.4%-0.6%

1.2. Operating Efficiency of Millennium Pharmacon International.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Millennium Pharmacon International is operating .

  • Measures how much profit Millennium Pharmacon International makes for each Rp1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Millennium Pharmacon International to the Medical Distribution industry mean.
  • An Operating Margin of 0.0% means the company generated Rp0.00  for each Rp1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Millennium Pharmacon International:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.0%-1.0%
TTM1.0%YOY2.4%-1.4%
TTM1.0%5Y2.0%-1.0%
5Y2.0%10Y1.1%+0.9%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.1%-3.1%
TTM1.0%2.6%-1.6%
YOY2.4%3.5%-1.1%
5Y2.0%3.3%-1.3%
10Y1.1%2.0%-0.9%
1.2.2. Operating Ratio

Measures how efficient Millennium Pharmacon International is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 1.89 means that the operating costs are Rp1.89 for each Rp1 in net sales.

Let's take a look of the Operating Ratio trends of Millennium Pharmacon International:

  • The MRQ is 1.887. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.881. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.887TTM1.881+0.007
TTM1.881YOY1.893-0.013
TTM1.8815Y1.892-0.011
5Y1.89210Y1.425+0.467
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8871.369+0.518
TTM1.8811.369+0.512
YOY1.8931.413+0.480
5Y1.8921.312+0.580
10Y1.4251.210+0.215

1.3. Liquidity of Millennium Pharmacon International.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Millennium Pharmacon International is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.14 means the company has Rp1.14 in assets for each Rp1 in short-term debts.

Let's take a look of the Current Ratio trends of Millennium Pharmacon International:

  • The MRQ is 1.142. The company is just able to pay all its short-term debts.
  • The TTM is 1.136. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.142TTM1.136+0.006
TTM1.136YOY1.142-0.007
TTM1.1365Y1.146-0.010
5Y1.14610Y0.602+0.543
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1421.366-0.224
TTM1.1361.418-0.282
YOY1.1421.403-0.261
5Y1.1461.408-0.262
10Y0.6021.299-0.697
1.3.2. Quick Ratio

Measures if Millennium Pharmacon International is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Millennium Pharmacon International to the Medical Distribution industry mean.
  • A Quick Ratio of 0.60 means the company can pay off Rp0.60 for each Rp1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Millennium Pharmacon International:

  • The MRQ is 0.601. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.567. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.601TTM0.567+0.034
TTM0.567YOY0.577-0.010
TTM0.5675Y0.577-0.010
5Y0.57710Y0.585-0.008
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6010.758-0.157
TTM0.5670.757-0.190
YOY0.5770.828-0.251
5Y0.5770.814-0.237
10Y0.5850.850-0.265

1.4. Solvency of Millennium Pharmacon International.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Millennium Pharmacon International assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Millennium Pharmacon International to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.82 means that Millennium Pharmacon International assets are financed with 81.5% credit (debt) and the remaining percentage (100% - 81.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Millennium Pharmacon International:

  • The MRQ is 0.815. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.816. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.815TTM0.816-0.001
TTM0.816YOY0.807+0.010
TTM0.8165Y0.811+0.005
5Y0.81110Y0.798+0.014
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8150.617+0.198
TTM0.8160.606+0.210
YOY0.8070.608+0.199
5Y0.8110.610+0.201
10Y0.7980.593+0.205
1.4.2. Debt to Equity Ratio

Measures if Millennium Pharmacon International is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Millennium Pharmacon International to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 440.7% means that company has Rp4.41 debt for each Rp1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Millennium Pharmacon International:

  • The MRQ is 4.407. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.449. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.407TTM4.449-0.042
TTM4.449YOY4.177+0.272
TTM4.4495Y4.303+0.146
5Y4.30310Y3.993+0.309
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4071.698+2.709
TTM4.4491.678+2.771
YOY4.1771.752+2.425
5Y4.3031.733+2.570
10Y3.9931.738+2.255

2. Market Valuation of Millennium Pharmacon International

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every Rp1 in earnings Millennium Pharmacon International generates.

  • Above 15 is considered overpriced but always compare Millennium Pharmacon International to the Medical Distribution industry mean.
  • A PE ratio of 14.09 means the investor is paying Rp14.09 for every Rp1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Millennium Pharmacon International:

  • The EOD is 12.849. Based on the earnings, the company is underpriced. +1
  • The MRQ is 14.090. Based on the earnings, the company is underpriced. +1
  • The TTM is 6.593. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD12.849MRQ14.090-1.241
MRQ14.090TTM6.593+7.497
TTM6.593YOY-18.846+25.439
TTM6.5935Y-10.975+17.567
5Y-10.97510Y9.386-20.361
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD12.84913.475-0.626
MRQ14.09014.623-0.533
TTM6.59318.845-12.252
YOY-18.84618.249-37.095
5Y-10.97517.230-28.205
10Y9.38619.682-10.296
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Millennium Pharmacon International:

  • The EOD is -0.632. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.693. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.936. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.632MRQ-0.693+0.061
MRQ-0.693TTM-0.936+0.244
TTM-0.936YOY1.004-1.940
TTM-0.9365Y-1.262+0.326
5Y-1.26210Y-0.249-1.013
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD-0.6326.313-6.945
MRQ-0.6934.510-5.203
TTM-0.9367.516-8.452
YOY1.0045.255-4.251
5Y-1.2622.484-3.746
10Y-0.2491.762-2.011
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Millennium Pharmacon International is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 0.71 means the investor is paying Rp0.71 for each Rp1 in book value.

Let's take a look of the Price to Book Ratio trends of Millennium Pharmacon International:

  • The EOD is 0.644. Based on the equity, the company is cheap. +2
  • The MRQ is 0.706. Based on the equity, the company is cheap. +2
  • The TTM is 0.977. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.644MRQ0.706-0.062
MRQ0.706TTM0.977-0.272
TTM0.977YOY0.661+0.317
TTM0.9775Y0.682+0.295
5Y0.68210Y0.750-0.068
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD0.6441.110-0.466
MRQ0.7061.178-0.472
TTM0.9771.224-0.247
YOY0.6611.307-0.646
5Y0.6821.386-0.704
10Y0.7502.166-1.416
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Millennium Pharmacon International compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.8215.655-50%3.424-18%2.294+23%3.425-18%
Book Value Per Share--225.278214.694+5%194.834+16%193.139+17%155.360+45%
Current Ratio--1.1421.136+1%1.1420%1.1460%0.602+90%
Debt To Asset Ratio--0.8150.8160%0.807+1%0.811+0%0.798+2%
Debt To Equity Ratio--4.4074.449-1%4.177+5%4.303+2%3.993+10%
Dividend Per Share--2.0002.0000%1.250+60%1.575+27%1.132+77%
Eps--2.82110.889-74%4.592-39%3.997-29%3.257-13%
Free Cash Flow Per Share---57.398-32.435-43%23.830-341%-16.833-71%-10.962-81%
Free Cash Flow To Equity Per Share--35.241-23.151+166%1.898+1756%-5.072+114%-1.087+103%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---9608.920--------
Intrinsic Value_10Y_min---7995.529--------
Intrinsic Value_1Y_max---188.338--------
Intrinsic Value_1Y_min---184.538--------
Intrinsic Value_3Y_max---1156.172--------
Intrinsic Value_3Y_min---1091.860--------
Intrinsic Value_5Y_max---2835.672--------
Intrinsic Value_5Y_min---2581.192--------
Market Cap184730000000.000-10%202566000000.000263081000000.000-23%163709000000.000+24%169060161200.000+20%143529155307.500+41%
Net Profit Margin--0.0040.008-51%0.007-42%0.005-11%0.006-27%
Operating Margin---0.010-100%0.024-100%0.020-100%0.011-100%
Operating Ratio--1.8871.881+0%1.8930%1.8920%1.425+32%
Pb Ratio0.644-10%0.7060.977-28%0.661+7%0.682+3%0.750-6%
Pe Ratio12.849-10%14.0906.593+114%-18.846+234%-10.975+178%9.386+50%
Price Per Share145.000-10%159.000206.500-23%128.500+24%132.700+20%112.660+41%
Price To Free Cash Flow Ratio-0.632+9%-0.693-0.936+35%1.004-169%-1.262+82%-0.249-64%
Price To Total Gains Ratio30.075-10%32.97950.293-34%4.367+655%-104.888+418%-21.662+166%
Quick Ratio--0.6010.567+6%0.577+4%0.577+4%0.585+3%
Return On Assets--0.0020.005-49%0.004-47%0.003-12%0.004-35%
Return On Equity--0.0130.025-49%0.023-46%0.014-13%0.018-29%
Total Gains Per Share--4.8217.655-37%4.674+3%3.869+25%4.557+6%
Usd Book Value--28700407.72727351974.166+5%24821890.400+16%24605918.807+17%19792918.108+45%
Usd Book Value Change Per Share--0.0000.001-50%0.000-18%0.000+23%0.000-18%
Usd Book Value Per Share--0.0230.021+5%0.019+16%0.019+17%0.016+45%
Usd Dividend Per Share--0.0000.0000%0.000+60%0.000+27%0.000+77%
Usd Eps--0.0000.001-74%0.000-39%0.000-29%0.000-13%
Usd Free Cash Flow---7312513.625-4132240.479-43%3035896.093-341%-2144526.607-71%-942684.280-87%
Usd Free Cash Flow Per Share---0.006-0.003-43%0.002-341%-0.002-71%-0.001-81%
Usd Free Cash Flow To Equity Per Share--0.004-0.002+166%0.000+1756%-0.001+114%0.000+103%
Usd Market Cap18473000.000-10%20256600.00026308100.000-23%16370900.000+24%16906016.120+20%14352915.531+41%
Usd Price Per Share0.015-10%0.0160.021-23%0.013+24%0.013+20%0.011+41%
Usd Profit--359423.805683983.941-47%584989.280-39%368527.428-2%344594.784+4%
Usd Revenue--87352609.74581180950.248+8%77770141.480+12%73181840.677+19%59877164.622+46%
Usd Total Gains Per Share--0.0000.001-37%0.000+3%0.000+25%0.000+6%
 EOD+3 -5MRQTTM+12 -21YOY+17 -185Y+18 -1710Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of Millennium Pharmacon International based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.849
Price to Book Ratio (EOD)Between0-10.644
Net Profit Margin (MRQ)Greater than00.004
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.601
Current Ratio (MRQ)Greater than11.142
Debt to Asset Ratio (MRQ)Less than10.815
Debt to Equity Ratio (MRQ)Less than14.407
Return on Equity (MRQ)Greater than0.150.013
Return on Assets (MRQ)Greater than0.050.002
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Millennium Pharmacon International based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.458
Ma 20Greater thanMa 50146.250
Ma 50Greater thanMa 100148.860
Ma 100Greater thanMa 200156.760
OpenGreater thanClose136.000
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in IDR. All numbers in thousands.

Summary
Total Assets1,551,779,568
Total Liabilities1,264,775,490
Total Stockholder Equity287,004,077
 As reported
Total Liabilities 1,264,775,490
Total Stockholder Equity+ 287,004,077
Total Assets = 1,551,779,568

Assets

Total Assets1,551,779,568
Total Current Assets1,407,478,926
Long-term Assets144,300,642
Total Current Assets
Cash And Cash Equivalents 16,857,974
Net Receivables 724,543,702
Inventory 515,260,984
Total Current Assets  (as reported)1,407,478,926
Total Current Assets  (calculated)1,256,662,661
+/- 150,816,265
Long-term Assets
Property Plant Equipment 48,425,711
Intangible Assets 7,863,483
Other Assets 30,819,488
Long-term Assets  (as reported)144,300,642
Long-term Assets  (calculated)87,108,682
+/- 57,191,959

Liabilities & Shareholders' Equity

Total Current Liabilities1,232,637,900
Long-term Liabilities32,144,088
Total Stockholder Equity287,004,077
Total Current Liabilities
Short-term Debt 703,553,816
Short Long Term Debt 703,553,816
Accounts payable 461,915,681
Total Current Liabilities  (as reported)1,232,637,900
Total Current Liabilities  (calculated)1,869,023,312
+/- 636,385,413
Long-term Liabilities
Long term Debt Total 885,745
Capital Lease Obligations 1,244,078
Long-term Liabilities  (as reported)32,144,088
Long-term Liabilities  (calculated)2,129,823
+/- 30,014,265
Total Stockholder Equity
Common Stock127,400,000
Retained Earnings 153,389,501
Capital Surplus 2,309,684
Other Stockholders Equity 3,904,892
Total Stockholder Equity (as reported)287,004,077
Total Stockholder Equity (calculated)287,004,077
+/- 0
Other
Capital Stock127,400,000
Cash and Short Term Investments 16,857,974
Common Stock Shares Outstanding 1,274,000
Liabilities and Stockholders Equity 1,551,779,568
Net Debt 686,695,842
Net Invested Capital 990,557,893
Net Working Capital 174,841,026
Property Plant and Equipment Gross 134,623,074



Balance Sheet

Currency in IDR. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-31
> Total Assets 
143,086,648
143,280,597
154,191,042
161,425,157
158,834,339
172,099,118
180,500,837
195,582,086
210,483,460
223,095,222
232,113,266
226,141,970
252,093,257
293,093,584
308,657,795
309,183,557
321,105,972
385,074,312
268,013,405
278,706,290
272,700,905
309,739,955
276,515,903
286,833,870
309,892,555
311,180,925
323,469,491
338,065,152
346,875,268
374,300,367
385,609,729
377,047,932
406,318,791
437,493,121
471,677,485
442,336,566
466,369,146
506,927,547
529,991,702
544,255,330
623,797,393
611,173,985
633,217,333
626,775,630
750,108,091
716,890,320
733,443,472
742,777,812
850,456,835
863,149,480
938,005,257
904,342,517
1,013,423,955
1,105,128,661
1,192,891,220
1,283,230,611
1,289,456,537
1,261,907,887
1,230,844,176
1,317,402,181
1,222,681,109
1,180,629,081
1,164,826,487
1,211,431,270
1,256,934,723
1,398,918,433
1,206,385,543
1,301,095,885
1,263,555,667
1,371,573,886
1,401,504,764
1,472,974,427
1,533,999,603
1,551,779,568
1,551,779,5681,533,999,6031,472,974,4271,401,504,7641,371,573,8861,263,555,6671,301,095,8851,206,385,5431,398,918,4331,256,934,7231,211,431,2701,164,826,4871,180,629,0811,222,681,1091,317,402,1811,230,844,1761,261,907,8871,289,456,5371,283,230,6111,192,891,2201,105,128,6611,013,423,955904,342,517938,005,257863,149,480850,456,835742,777,812733,443,472716,890,320750,108,091626,775,630633,217,333611,173,985623,797,393544,255,330529,991,702506,927,547466,369,146442,336,566471,677,485437,493,121406,318,791377,047,932385,609,729374,300,367346,875,268338,065,152323,469,491311,180,925309,892,555286,833,870276,515,903309,739,955272,700,905278,706,290268,013,405385,074,312321,105,972309,183,557308,657,795293,093,584252,093,257226,141,970232,113,266223,095,222210,483,460195,582,086180,500,837172,099,118158,834,339161,425,157154,191,042143,280,597143,086,648
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,008,954,260
1,093,923,909
1,182,193,633
1,182,209,007
1,153,601,797
1,110,540,241
1,195,776,855
1,103,592,128
1,063,453,249
1,028,893,090
1,076,776,627
1,133,463,032
1,277,627,200
1,070,304,632
1,165,336,568
1,135,969,263
1,242,358,468
1,258,958,580
1,328,424,301
1,391,260,421
1,407,478,926
1,407,478,9261,391,260,4211,328,424,3011,258,958,5801,242,358,4681,135,969,2631,165,336,5681,070,304,6321,277,627,2001,133,463,0321,076,776,6271,028,893,0901,063,453,2491,103,592,1281,195,776,8551,110,540,2411,153,601,7971,182,209,0071,182,193,6331,093,923,9091,008,954,26000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,183,833
37,685,486
37,508,605
43,619,164
40,381,356
29,490,800
49,108,643
37,314,162
73,058,729
48,054,345
13,830,906
23,218,454
10,465,404
47,362,351
19,369,152
14,714,376
20,011,742
25,668,366
15,838,886
37,587,375
16,857,974
16,857,97437,587,37515,838,88625,668,36620,011,74214,714,37619,369,15247,362,35110,465,40423,218,45413,830,90648,054,34573,058,72937,314,16249,108,64329,490,80040,381,35643,619,16437,508,60537,685,48637,183,83300000000000000000000000000000000000000000000000000000
       Net Receivables 
58,506,711
60,453,682
69,305,979
71,059,083
74,631,319
80,182,808
84,507,301
90,621,688
104,508,974
103,900,657
106,072,714
106,394,193
127,664,981
132,650,146
135,200,286
147,485,390
157,091,920
179,452,599
125,373,709
131,451,692
130,890,940
138,863,264
127,242,881
138,813,059
148,028,158
147,203,078
147,616,865
159,957,579
167,491,814
174,631,070
178,159,474
180,853,505
188,493,705
206,112,708
209,779,676
203,435,888
209,759,962
221,756,627
221,049,785
240,921,946
272,101,769
295,545,545
276,407,386
302,557,095
341,742,479
341,760,586
312,397,465
341,879,940
378,766,316
372,370,226
351,338,687
394,663,890
456,099,997
504,489,883
500,563,865
555,883,037
565,237,146
550,018,863
506,661,109
601,535,287
509,356,839
490,078,276
498,760,585
541,901,586
604,405,505
617,143,236
461,074,464
563,205,990
572,523,549
636,139,901
545,672,462
612,059,833
719,937,870
724,543,702
724,543,702719,937,870612,059,833545,672,462636,139,901572,523,549563,205,990461,074,464617,143,236604,405,505541,901,586498,760,585490,078,276509,356,839601,535,287506,661,109550,018,863565,237,146555,883,037500,563,865504,489,883456,099,997394,663,890351,338,687372,370,226378,766,316341,879,940312,397,465341,760,586341,742,479302,557,095276,407,386295,545,545272,101,769240,921,946221,049,785221,756,627209,759,962203,435,888209,779,676206,112,708188,493,705180,853,505178,159,474174,631,070167,491,814159,957,579147,616,865147,203,078148,028,158138,813,059127,242,881138,863,264130,890,940131,451,692125,373,709179,452,599157,091,920147,485,390135,200,286132,650,146127,664,981106,394,193106,072,714103,900,657104,508,97490,621,68884,507,30180,182,80874,631,31971,059,08369,305,97960,453,68258,506,711
       Other Current Assets 
5,154,654
5,089,450
4,562,602
4,063,583
4,085,529
5,339,022
6,411,622
5,119,966
5,282,403
6,655,344
4,211,814
4,836,201
6,182,871
10,611,753
6,500,008
9,691,896
8,820,359
14,537,558
5,854,629
8,296,994
10,615,680
13,226,627
7,239,957
6,778,224
8,973,846
11,235,422
12,822,335
11,927,045
13,412,384
17,878,346
19,290,867
17,961,928
23,671,051
27,483,404
31,298,699
28,502,438
34,362,805
41,220,779
27,280,667
28,238,110
38,505,966
41,208,845
48,540,712
49,068,587
66,314,822
74,970,842
73,814,734
80,874,644
97,314,857
104,287,476
112,737,587
55,080,219
66,452,647
73,773,401
89,969,881
97,238,609
106,815,292
120,821,107
97,480,735
98,101,999
91,643,757
81,296,242
91,514,688
107,758,083
74,628,816
105,163,547
107,476,087
114,623,701
88,381,451
107,057,757
0
0
104,048,796
0
0104,048,79600107,057,75788,381,451114,623,701107,476,087105,163,54774,628,816107,758,08391,514,68881,296,24291,643,75798,101,99997,480,735120,821,107106,815,29297,238,60989,969,88173,773,40166,452,64755,080,219112,737,587104,287,47697,314,85780,874,64473,814,73474,970,84266,314,82249,068,58748,540,71241,208,84538,505,96628,238,11027,280,66741,220,77934,362,80528,502,43831,298,69927,483,40423,671,05117,961,92819,290,86717,878,34613,412,38411,927,04512,822,33511,235,4228,973,8466,778,2247,239,95713,226,62710,615,6808,296,9945,854,62914,537,5588,820,3599,691,8966,500,00810,611,7536,182,8714,836,2014,211,8146,655,3445,282,4035,119,9666,411,6225,339,0224,085,5294,063,5834,562,6025,089,4505,154,654
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
101,036,978
107,247,530
108,306,090
120,303,935
121,625,325
119,088,981
117,175,831
135,933,397
134,654,643
123,471,691
121,291,232
136,080,911
135,759,317
127,586,404
129,215,417
142,546,184
144,550,126
142,739,182
144,300,642
144,300,642142,739,182144,550,126142,546,184129,215,417127,586,404135,759,317136,080,911121,291,232123,471,691134,654,643135,933,397117,175,831119,088,981121,625,325120,303,935108,306,090107,247,530101,036,9780000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
7,810,208
7,557,555
7,293,714
6,988,832
6,906,126
6,932,954
6,920,247
6,616,883
8,039,673
8,806,096
8,807,178
9,739,985
9,790,887
9,544,663
18,053,836
9,128,390
9,506,969
9,115,555
8,916,736
8,570,039
8,074,903
7,743,956
7,667,169
7,404,923
7,241,962
7,172,582
8,064,978
7,935,710
7,621,276
7,751,097
7,242,471
7,592,273
7,576,264
7,995,620
8,292,140
10,696,025
10,380,313
9,818,604
11,144,161
10,760,497
10,445,498
10,290,605
10,420,551
10,940,254
10,956,685
11,295,598
15,434,970
15,110,953
15,021,792
14,649,981
18,197,201
18,701,460
19,072,547
19,205,079
19,895,955
19,937,634
20,993,545
20,848,408
24,821,573
23,515,990
22,501,379
21,777,856
48,138,668
45,714,641
44,527,312
43,108,127
42,286,872
40,171,976
45,976,952
35,940,305
41,800,224
42,006,048
46,904,022
48,425,711
48,425,71146,904,02242,006,04841,800,22435,940,30545,976,95240,171,97642,286,87243,108,12744,527,31245,714,64148,138,66821,777,85622,501,37923,515,99024,821,57320,848,40820,993,54519,937,63419,895,95519,205,07919,072,54718,701,46018,197,20114,649,98115,021,79215,110,95315,434,97011,295,59810,956,68510,940,25410,420,55110,290,60510,445,49810,760,49711,144,1619,818,60410,380,31310,696,0258,292,1407,995,6207,576,2647,592,2737,242,4717,751,0977,621,2767,935,7108,064,9787,172,5827,241,9627,404,9237,667,1697,743,9568,074,9038,570,0398,916,7369,115,5559,506,9699,128,39018,053,8369,544,6639,790,8879,739,9858,807,1788,806,0968,039,6736,616,8836,920,2476,932,9546,906,1266,988,8327,293,7147,557,5557,810,208
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,000,000
54,000,000
54,000,000
54,000,000
54,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000054,000,00054,000,00054,000,00054,000,00054,000,00000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,925,748
9,095,689
11,024,099
12,137,313
12,129,156
12,058,542
11,676,841
11,715,008
11,254,911
10,794,814
10,334,717
9,874,621
9,414,524
8,954,427
8,494,330
8,034,233
7,574,137
7,114,040
6,653,943
6,193,846
5,733,749
5,273,652
4,813,556
4,353,459
3,893,362
3,433,265
2,973,168
2,513,072
2,052,975
1,592,878
1,132,781
672,684
154,192
125,194
96,196
67,198
38,199
15,571
0
0
0
4,327,985
4,327,985
4,327,985
4,327,985
4,327,985
4,327,985
4,327,985
4,327,985
4,430,061
4,895,200
4,895,200
4,895,200
4,895,200
13,923,644
8,737,203
8,445,963
8,154,723
7,863,483
7,863,4838,154,7238,445,9638,737,20313,923,6444,895,2004,895,2004,895,2004,895,2004,430,0614,327,9854,327,9854,327,9854,327,9854,327,9854,327,9854,327,9854,327,98500015,57138,19967,19896,196125,194154,192672,6841,132,7811,592,8782,052,9752,513,0722,973,1683,433,2653,893,3624,353,4594,813,5565,273,6525,733,7496,193,8466,653,9437,114,0407,574,1378,034,2338,494,3308,954,4279,414,5249,874,62110,334,71710,794,81411,254,91111,715,00811,676,84112,058,54212,129,15612,137,31311,024,0999,095,6898,925,748000000000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,595,120
1,441,394
2,806,834
581,139
940,845
1,096,859
1,775,778
755,639
1,597,102
1,723,725
873,098
1,600,549
3,890,021
1,963,359
1,979,375
2,001,882
2,760,903
5,127,305
7,782,586
7,782,5865,127,3052,760,9032,001,8821,979,3751,963,3593,890,0211,600,549873,0981,723,7251,597,102755,6391,775,7781,096,859940,845581,1392,806,8341,441,3941,595,1200000000000000000000000000000000000000000000000000000000
> Total Liabilities 
95,959,814
94,157,483
102,905,464
109,218,819
104,100,684
115,044,742
121,470,648
132,290,581
144,329,628
155,090,542
161,877,106
153,123,892
176,835,683
214,932,506
228,902,197
225,338,901
234,667,683
296,036,152
178,745,667
189,423,551
183,868,875
220,877,142
185,740,756
195,312,041
217,566,594
217,914,800
228,692,829
240,773,235
247,150,939
272,640,888
280,984,842
269,760,765
296,883,272
325,046,009
356,805,309
325,069,299
348,830,376
388,615,236
408,202,810
420,366,648
495,445,002
479,717,274
498,902,536
491,482,271
608,846,295
575,525,133
590,167,165
596,862,128
701,777,572
710,541,750
725,390,568
688,375,408
790,761,017
876,581,237
960,783,280
1,047,075,511
1,053,986,167
1,025,121,039
995,406,360
1,075,189,012
980,974,672
940,335,772
935,629,998
981,344,026
1,022,898,687
1,158,180,010
969,406,193
1,053,012,972
1,013,930,668
1,113,385,532
1,142,594,626
1,208,219,515
1,250,589,764
1,264,775,490
1,264,775,4901,250,589,7641,208,219,5151,142,594,6261,113,385,5321,013,930,6681,053,012,972969,406,1931,158,180,0101,022,898,687981,344,026935,629,998940,335,772980,974,6721,075,189,012995,406,3601,025,121,0391,053,986,1671,047,075,511960,783,280876,581,237790,761,017688,375,408725,390,568710,541,750701,777,572596,862,128590,167,165575,525,133608,846,295491,482,271498,902,536479,717,274495,445,002420,366,648408,202,810388,615,236348,830,376325,069,299356,805,309325,046,009296,883,272269,760,765280,984,842272,640,888247,150,939240,773,235228,692,829217,914,800217,566,594195,312,041185,740,756220,877,142183,868,875189,423,551178,745,667296,036,152234,667,683225,338,901228,902,197214,932,506176,835,683153,123,892161,877,106155,090,542144,329,628132,290,581121,470,648115,044,742104,100,684109,218,819102,905,46494,157,48395,959,814
   > Total Current Liabilities 
95,589,035
93,316,930
101,177,391
108,690,034
103,512,343
114,357,696
120,668,054
131,081,891
142,841,496
151,400,462
159,171,869
149,570,123
172,806,325
201,807,730
217,595,857
213,578,481
221,801,208
282,483,976
164,239,418
181,335,297
175,434,783
211,843,051
176,392,581
185,286,339
206,963,714
206,734,637
217,432,110
228,732,843
234,331,262
259,207,831
266,856,403
254,814,552
281,119,718
308,465,557
340,302,714
307,620,405
330,435,184
369,273,746
387,957,626
398,905,414
474,184,751
457,541,495
477,434,634
469,077,840
587,183,957
552,950,670
568,066,597
573,746,212
676,934,723
684,561,130
699,571,401
661,393,219
765,595,243
850,208,159
935,926,819
1,020,952,988
1,026,730,793
996,499,169
966,343,569
1,045,408,018
953,542,828
911,602,321
903,258,284
947,540,200
993,391,859
1,130,796,541
942,588,717
1,024,983,262
984,687,735
1,086,284,417
1,113,038,489
1,177,424,794
1,219,017,274
1,232,637,900
1,232,637,9001,219,017,2741,177,424,7941,113,038,4891,086,284,417984,687,7351,024,983,262942,588,7171,130,796,541993,391,859947,540,200903,258,284911,602,321953,542,8281,045,408,018966,343,569996,499,1691,026,730,7931,020,952,988935,926,819850,208,159765,595,243661,393,219699,571,401684,561,130676,934,723573,746,212568,066,597552,950,670587,183,957469,077,840477,434,634457,541,495474,184,751398,905,414387,957,626369,273,746330,435,184307,620,405340,302,714308,465,557281,119,718254,814,552266,856,403259,207,831234,331,262228,732,843217,432,110206,734,637206,963,714185,286,339176,392,581211,843,051175,434,783181,335,297164,239,418282,483,976221,801,208213,578,481217,595,857201,807,730172,806,325149,570,123159,171,869151,400,462142,841,496131,081,891120,668,054114,357,696103,512,343108,690,034101,177,39193,316,93095,589,035
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
490,682,529
607,102,155
583,770,501
492,687,883
543,804,239
633,114,574
474,916,619
382,990,537
457,977,522
448,743,388
627,709,526
454,720,981
475,643,788
479,315,965
545,676,072
566,080,352
672,909,852
653,723,112
703,553,816
703,553,816653,723,112672,909,852566,080,352545,676,072479,315,965475,643,788454,720,981627,709,526448,743,388457,977,522382,990,537474,916,619633,114,574543,804,239492,687,883583,770,501607,102,155490,682,5290000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
490,682,529
607,102,155
583,770,501
492,687,883
543,804,239
633,114,574
474,916,619
383,386,537
457,977,522
448,743,388
627,709,526
454,720,981
475,643,788
479,315,965
545,676,072
566,080,352
672,909,852
653,723,112
703,553,816
703,553,816653,723,112672,909,852566,080,352545,676,072479,315,965475,643,788454,720,981627,709,526448,743,388457,977,522383,386,537474,916,619633,114,574543,804,239492,687,883583,770,501607,102,155490,682,5290000000000000000000000000000000000000000000000000000000
       Accounts payable 
69,024,901
63,951,369
75,753,227
77,251,006
74,463,209
81,618,967
90,765,599
109,158,016
103,872,799
113,701,903
120,624,875
115,904,855
128,929,170
142,627,330
135,780,599
136,488,517
140,528,879
164,753,002
83,406,559
85,703,974
72,717,114
92,707,512
70,938,500
79,064,285
85,368,258
71,341,837
99,440,257
93,843,840
106,134,893
127,031,901
137,996,475
123,781,279
136,216,145
132,596,915
159,085,884
155,097,090
153,494,099
161,908,453
150,347,241
183,456,193
214,157,400
166,414,738
195,848,239
160,866,184
257,975,040
151,854,317
247,867,729
272,499,309
353,935,840
307,341,185
316,277,174
327,629,111
314,433,131
313,183,785
430,113,976
479,892,792
375,055,468
366,998,164
424,680,051
445,953,629
267,328,026
323,419,825
408,523,785
372,894,032
455,458,357
418,208,524
413,382,847
469,789,443
439,744,894
471,477,115
468,603,853
445,448,828
506,686,233
461,915,681
461,915,681506,686,233445,448,828468,603,853471,477,115439,744,894469,789,443413,382,847418,208,524455,458,357372,894,032408,523,785323,419,825267,328,026445,953,629424,680,051366,998,164375,055,468479,892,792430,113,976313,183,785314,433,131327,629,111316,277,174307,341,185353,935,840272,499,309247,867,729151,854,317257,975,040160,866,184195,848,239166,414,738214,157,400183,456,193150,347,241161,908,453153,494,099155,097,090159,085,884132,596,915136,216,145123,781,279137,996,475127,031,901106,134,89393,843,84099,440,25771,341,83785,368,25879,064,28570,938,50092,707,51272,717,11485,703,97483,406,559164,753,002140,528,879136,488,517135,780,599142,627,330128,929,170115,904,855120,624,875113,701,903103,872,799109,158,01690,765,59981,618,96774,463,20977,251,00675,753,22763,951,36969,024,901
       Other Current Liabilities 
3,411,304
4,256,822
3,353,629
4,624,212
2,863,914
3,707,464
5,757,189
2,533,601
4,442,734
5,717,862
2,438,774
5,721,278
8,493,792
11,333,010
8,808,081
12,672,544
14,619,192
34,210,576
10,118,189
13,481,333
12,378,708
11,849,952
9,229,236
11,050,127
11,912,208
10,547,503
10,311,589
14,333,781
14,654,730
15,583,532
13,993,133
16,651,137
18,684,394
19,629,992
19,094,936
18,025,253
22,535,537
23,193,208
21,110,493
24,822,281
26,936,803
15,839,513
22,781,861
26,855,714
28,604,630
30,354,675
24,016,887
27,442,603
30,005,463
27,392,591
38,819,388
28,627,213
31,296,455
12,284,601
6,799,674
7,847,461
10,538,494
10,376,886
5,542,826
8,608,965
10,810,816
8,468,350
7,389,465
7,729,292
7,996,807
9,984,690
5,240,118
8,572,913
6,495,507
11,088,980
2,681,209
4,746,086
10,357,620
0
010,357,6204,746,0862,681,20911,088,9806,495,5078,572,9135,240,1189,984,6907,996,8077,729,2927,389,4658,468,35010,810,8168,608,9655,542,82610,376,88610,538,4947,847,4616,799,67412,284,60131,296,45528,627,21338,819,38827,392,59130,005,46327,442,60324,016,88730,354,67528,604,63026,855,71422,781,86115,839,51326,936,80324,822,28121,110,49323,193,20822,535,53718,025,25319,094,93619,629,99218,684,39416,651,13713,993,13315,583,53214,654,73014,333,78110,311,58910,547,50311,912,20811,050,1279,229,23611,849,95212,378,70813,481,33310,118,18934,210,57614,619,19212,672,5448,808,08111,333,0108,493,7925,721,2782,438,7745,717,8624,442,7342,533,6015,757,1893,707,4642,863,9144,624,2123,353,6294,256,8223,411,304
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,122,523
27,255,374
28,621,870
29,062,791
29,780,995
27,431,844
28,733,451
32,371,714
33,803,826
29,506,828
27,383,469
26,817,476
28,029,709
29,242,933
27,101,115
29,556,137
30,794,721
31,572,490
32,144,088
32,144,08831,572,49030,794,72129,556,13727,101,11529,242,93328,029,70926,817,47627,383,46929,506,82833,803,82632,371,71428,733,45127,431,84429,780,99529,062,79128,621,87027,255,37426,122,5230000000000000000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,030,202
2,081,356
2,133,589
2,148,159
1,798,209
1,845,231
1,893,244
1,471,254
1,509,641
1,543,782
1,117,108
885,745
885,7451,117,1081,543,7821,509,6411,471,2541,893,2441,845,2311,798,2092,148,1592,133,5892,081,3562,030,20200000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
47,126,834
49,123,115
51,285,578
52,206,337
54,733,655
57,054,376
59,030,189
63,291,505
66,153,832
68,004,680
70,236,160
73,018,078
75,257,574
78,161,079
79,755,598
83,844,655
86,438,289
89,038,160
89,267,738
89,282,740
88,832,030
88,862,812
90,775,148
91,521,829
92,325,962
93,266,125
94,776,663
97,291,916
99,724,329
101,659,478
104,624,887
107,287,167
109,435,518
112,447,112
114,872,176
117,267,267
117,538,770
118,312,311
121,788,893
123,888,683
128,352,391
131,456,711
134,314,797
135,293,359
141,261,795
141,365,187
143,276,307
145,915,685
148,679,263
152,607,729
212,614,689
215,967,108
222,662,938
228,547,425
232,107,941
236,155,099
235,470,370
236,786,848
235,437,816
242,213,168
241,706,437
240,293,308
229,196,489
230,087,244
234,036,036
240,738,422
236,979,350
248,082,914
249,624,999
258,188,354
258,910,138
264,754,912
283,409,839
287,004,077
287,004,077283,409,839264,754,912258,910,138258,188,354249,624,999248,082,914236,979,350240,738,422234,036,036230,087,244229,196,489240,293,308241,706,437242,213,168235,437,816236,786,848235,470,370236,155,099232,107,941228,547,425222,662,938215,967,108212,614,689152,607,729148,679,263145,915,685143,276,307141,365,187141,261,795135,293,359134,314,797131,456,711128,352,391123,888,683121,788,893118,312,311117,538,770117,267,267114,872,176112,447,112109,435,518107,287,167104,624,887101,659,47899,724,32997,291,91694,776,66393,266,12592,325,96291,521,82990,775,14888,862,81288,832,03089,282,74089,267,73889,038,16086,438,28983,844,65579,755,59878,161,07975,257,57473,018,07870,236,16068,004,68066,153,83263,291,50559,030,18957,054,37654,733,65552,206,33751,285,57849,123,11547,126,834
   Common Stock
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
72,800,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000
127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,000127,400,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,00072,800,000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,309,684
2,309,684
2,309,684
2,309,684
2,309,684
2,309,684
2,309,684
2,309,684
2,309,684
2,309,684
2,309,684
2,309,684
2,309,684
2,309,684
2,309,684
2,309,684
2,309,684
2,309,6842,309,6842,309,6842,309,6842,309,6842,309,6842,309,6842,309,6842,309,6842,309,6842,309,6842,309,6842,309,6842,309,6842,309,6842,309,6842,309,684000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,904,892
3,904,892
3,904,8923,904,892000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in IDR. All numbers in thousands.




Cash Flow

Currency in IDR. All numbers in thousands.




Income Statement

Currency in IDR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,247,238,010
Cost of Revenue-2,964,009,901
Gross Profit283,228,109283,228,109
 
Operating Income (+$)
Gross Profit283,228,109
Operating Expense-3,145,206,435
Operating Income102,031,575-2,861,978,326
 
Operating Expense (+$)
Research Development-
Selling General Administrative59,117,987
Selling And Marketing Expenses-
Operating Expense3,145,206,43559,117,987
 
Net Interest Income (+$)
Interest Income964,812
Interest Expense-51,843,379
Other Finance Cost-0
Net Interest Income-50,878,567
 
Pretax Income (+$)
Operating Income102,031,575
Net Interest Income-50,878,567
Other Non-Operating Income Expenses-
Income Before Tax (EBT)40,778,397102,031,575
EBIT - interestExpense = -51,843,379
27,352,860
79,196,240
Interest Expense51,843,379
Earnings Before Interest and Taxes (EBIT)-92,621,777
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax40,778,397
Tax Provision-13,425,537
Net Income From Continuing Ops27,352,86027,352,860
Net Income27,352,860
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-50,878,567
 

Technical Analysis of Millennium Pharmacon International
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Millennium Pharmacon International. The general trend of Millennium Pharmacon International is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Millennium Pharmacon International's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Millennium Pharmacon International.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 148.00 < 150.00 < 150.00.

The bearish price targets are: 143.00 > 135.00 > 135.00.

Tweet this
Millennium Pharmacon International Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Millennium Pharmacon International. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Millennium Pharmacon International Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Millennium Pharmacon International. The current macd is -0.21675011.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Millennium Pharmacon International price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Millennium Pharmacon International. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Millennium Pharmacon International price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Millennium Pharmacon International Daily Moving Average Convergence/Divergence (MACD) ChartMillennium Pharmacon International Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Millennium Pharmacon International. The current adx is 16.89.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Millennium Pharmacon International shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Millennium Pharmacon International Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Millennium Pharmacon International. The current sar is 153.00.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Millennium Pharmacon International Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Millennium Pharmacon International. The current rsi is 45.46. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Millennium Pharmacon International Daily Relative Strength Index (RSI) ChartMillennium Pharmacon International Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Millennium Pharmacon International. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Millennium Pharmacon International price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Millennium Pharmacon International Daily Stochastic Oscillator ChartMillennium Pharmacon International Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Millennium Pharmacon International. The current cci is -92.50398724.

Millennium Pharmacon International Daily Commodity Channel Index (CCI) ChartMillennium Pharmacon International Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Millennium Pharmacon International. The current cmo is -11.83126828.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Millennium Pharmacon International Daily Chande Momentum Oscillator (CMO) ChartMillennium Pharmacon International Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Millennium Pharmacon International. The current willr is -44.44444444.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Millennium Pharmacon International is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Millennium Pharmacon International Daily Williams %R ChartMillennium Pharmacon International Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Millennium Pharmacon International.

Millennium Pharmacon International Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Millennium Pharmacon International. The current atr is 8.51095619.

Millennium Pharmacon International Daily Average True Range (ATR) ChartMillennium Pharmacon International Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Millennium Pharmacon International. The current obv is 841,677,900.

Millennium Pharmacon International Daily On-Balance Volume (OBV) ChartMillennium Pharmacon International Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Millennium Pharmacon International. The current mfi is 56.96.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Millennium Pharmacon International Daily Money Flow Index (MFI) ChartMillennium Pharmacon International Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Millennium Pharmacon International.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Millennium Pharmacon International Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Millennium Pharmacon International based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.458
Ma 20Greater thanMa 50146.250
Ma 50Greater thanMa 100148.860
Ma 100Greater thanMa 200156.760
OpenGreater thanClose136.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Millennium Pharmacon International with someone you think should read this too:
  • Are you bullish or bearish on Millennium Pharmacon International? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Millennium Pharmacon International? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Millennium Pharmacon International

I send you an email if I find something interesting about Millennium Pharmacon International.


Comments

How you think about this?

Leave a comment

Stay informed about Millennium Pharmacon International.

Receive notifications about Millennium Pharmacon International in your mailbox!